Immunocore Holdings PLC
NASDAQ:IMCR
Immunocore Holdings PLC
NASDAQ:IMCR
Price:
60.23 USD
1.29%
Market Closed
Updated:
May 5, 2024
Immunocore Holdings PLC
Revenue
|
Immunocore Holdings PLC
Revenue Peer Comparison
Comparables:
CNTA
EXAI
AUTL
BCYC
GNS
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Revenue
£249.4m
|
CAGR 3-Years
102%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Revenue
$6.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Exscientia PLC
NASDAQ:EXAI
|
Revenue
£20.1m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Revenue
$1.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Revenue
$41.6m
|
CAGR 3-Years
55%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Revenue
£673.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
Immunocore Holdings PLC
Revenue Breakdown
Breakdown by Geography
Immunocore Holdings PLC
Immunocore Holdings PLC
|
Total Revenue:
249.4m
GBP
|
|
United States:
169.8m
GBP
|
|
Europe:
67.6m
GBP
|
|
The Continent Of Rest Of World For Countries:
1.3m
GBP
|
Breakdown by Segments
Immunocore Holdings PLC
Immunocore Holdings PLC
|
Total Revenue:
249.4m
GBP
|
|
Product Revenue, Net:
238.7m
GBP
|
See Also
What is Immunocore Holdings PLC's Revenue?
Revenue
249.4m
GBP
249.4m
GBP
Based on the financial report for Dec 31, 2023, Immunocore Holdings PLC's Revenue amounts to 249.4m GBP.
What is Immunocore Holdings PLC's Revenue growth rate?
Revenue CAGR 5Y
60%
60%
Over the last year, the Revenue growth was 74%. The average annual Revenue growth rates for Immunocore Holdings PLC have been 102% over the past three years , 60% over the past five years .
You don't have any saved screeners yet
